01/27/2026 11:00
Bial Achieves Key Milestone in Phase 2b ACTIVATE Study of BIA 28-6156 in GBA1-Associated Parkinson’s Disease

Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that 75% of patients currently enrolled in its ongoing Phase 2b clinical study ACTIVATE (ClinicalTrials.gov identifier: NCT05819359) have completed the double-blind treatment period through week 78. This operational milestone represents a significant step toward the completion of the ACTIVATE study, which is evaluating the efficacy, safety, tolerability, pharmacodynamics, and pharm...

Topshots of the Week (1-7 July, 2023)

Selection of some of the most striking photographs taken by AFP photojournalists this past week (1-7 July, 2023).


Stork fly over a burning field in Ukraine

Stork fly over a burning field near town of Snigurivka, Mykolaiv region on July 4, 2023, amid Russian invasion in Ukraine.
© Anatolii STEPANOV / AFP

Topshots of the Week (17-23 June, 2023)

Selection of some of the most striking photographs taken by AFP photojournalists this past week (17-23 June, 2023).


Boy covers himself with a cloth, India

A boy covers himself with a cloth while walking along a street, as it rains in Chennai on June 19, 2023.
© R.Satish BABU / AFP

Subscribe to